| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.0043 | 0.9 |
| mRNA | AZD6244 | UHNBreast | pan-cancer | AAC | 0.036 | 0.9 |
| mRNA | ISOX | CTRPv2 | pan-cancer | AAC | -0.0037 | 0.9 |
| mRNA | ZG-10 | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.0053 | 0.9 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.9 |